West Pharmaceutical Services | WST - Ativos





Ativos Alterar Data
Align Technology USD 6.52B 103.03M 2026-09
Baxter International USD 19.41B 377M 2026-09
Becton, Dickinson and Co. USD 50.79B 60M 2026-09
Cerus USD 221.86M 6.67M 2025-12
Charles River Laboratories USD 7.45B 80.64M 2026-09
Cooper Companies USD 12.67B 191.1M 2026-06
Dentsply International USD 5.19B 14M 2026-09
Haemonetics USD 2.41B 45.2M 2026-09
ICU Medical USD 3.94B 27.48M 2026-09
Insulet USD 3.42B 250M 2026-09
Integra LifeSciences USD 3.51B 55.69M 2026-09
IQVIA Holdings USD 30.47B 593M 2026-09
J&J USD 197.42B 3.64B 2026-09
Medtronic USD 93.31B 278M 2026-06
Merit Medical Systems USD 2.92B 61.29M 2026-09
Neogen USD 3.3B 42.8M 2026-06
OraSure Technologies USD 360.55M 18.62M 2026-06
Quidel USD 5.78B 66M 2026-09
Repligen USD 2.93B 23.77M 2026-09
Rockwell Medical USD 52.62M 1.34M 2025-06
Solventum Corp USD 14.16B 78M 2026-09
STAAR Surgical USD 485.16M 9.95M 2026-09
Terumo JPY 2.37T 61.86B 2026-06
Utah Medical Products USD 124.38M 1.84M 2026-03
West Pharmaceutical Services USD 4.06B 15.7M 2026-09